Published on in Vol 14 (2025)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/71038, first published .
Implementation and Evaluation of a Best Practice Advisory to Reduce Inequities in Technology Use for People With Type 1 Diabetes: Protocol for a Mixed Methods, Nonrandomized Controlled Trial

Implementation and Evaluation of a Best Practice Advisory to Reduce Inequities in Technology Use for People With Type 1 Diabetes: Protocol for a Mixed Methods, Nonrandomized Controlled Trial

Implementation and Evaluation of a Best Practice Advisory to Reduce Inequities in Technology Use for People With Type 1 Diabetes: Protocol for a Mixed Methods, Nonrandomized Controlled Trial

Nestoras Mathioudakis   1 * , MD, MHS ;   Risa Wolf   2 * , MD ;   Abha Choudhary   3 , MD ;   Georgia Davis   4 , MD ;   Mary Pat Gallagher   5 , MD ;   Meenal Gupta   6 , MD ;   Manmohan Kamboj   7 , MD ;   Nicole Rioles   8 , MA ;   Emma Ospelt   8 , MPH ;   Susan Thapa   8 , MS, PhD ;   Ruth S Weinstock   9 , MD, PhD ;   Trevon Wright   8 , MHA ;   Osagie Ebekozien   8 , MD, MPH

1 Division of Endocrinology, Diabetes & Metabolism, Department of Medicine, Johns Hopkins University, Baltimore, MD, United States

2 Division of Pediatric Endocrinology, Department of Pediatrics, Johns Hopkins University, Baltimore, MD, United States

3 Division of Endocrinology, Department of Pediatrics, The University of Texas Southwestern Medical Center, Dallas, TX, United States

4 Division of Endocrinology, Metabolism & Lipids, Department of Medicine, Emory University, Grady Memorial Hospital, Atlanta, GA, United States

5 NYU Langone Health, New York, NY, United States

6 Seattle Children's Hospital, Seattle, WA, United States

7 Division of Endocrinology, Department of Pediatrics at the Ohio State University, Nationwide Children's Hospital, Columbus, OH, United States

8 T1D Exchange, Boston, MA, United States

9 SUNY Upstate Medical University, Syracuse, NY, United States

*these authors contributed equally

Corresponding Author:

  • Nestoras Mathioudakis, MD, MHS
  • Division of Endocrinology, Diabetes & Metabolism
  • Department of Medicine
  • Johns Hopkins University
  • 1830 E. Monument Street
  • Suite 333
  • Baltimore, MD 21287
  • United States
  • Phone: 1 667-306-8085
  • Fax: 1 410-367-2042
  • Email: nmathio1@jhmi.edu